Fig 1.
Flowchart of patient inclusion in the study and outcomes.
CIN: Cervical Intraepithelial Neoplasia; ZT: Transformation Zone; no follow-up proposal: cases in which immediate treatment was proposed but the patient did not return for treatment; biopsy failure: cases in which a worse lesion was detected in the first follow-up visit.
Table 1.
Clinical and laboratory characteristics of Included Patients.
Fig 2.
Kaplan-Meier Curves (1-survival): (A) Proportion of regression over time, (B) Proportion of progression over time.
Time: time in days since the biopsy. Cross marks (+) indicate censored observations (women who had not yet regressed (A) or progressed (B) or were lost to observation at the time of censoring). Median time to regression = 357 days (SE = 61.4 days; 95% CI: 236.6–477.4 days); median time to progression = 966 days (SE = 159.1 days; 95% CI: 654.1–1277.9 days).
Table 2.
Bivariate Analysis: association of baseline characteristics and outcomes.